Breakthrough Vaccine to Potentially Protect Against the Spread of COVID-19
At Pfizer, we are working at an unprecedented speed to develop, test and manufacture an mRNA-based vaccine to prevent COVID-19.We operate one of the most sophisticated supply chain systems in the industry, with more than 40 Pfizer-owned sites and more than 200 suppliers globally.mRNA is a new mechanism for vaccine creation that requires rapid development and scale-up of novel manufacturing technologies.
Read more...